March 25, 2008 — A class 1 recall has been announced for Medtronic Neuromodulation's implantable infusion pumps, the US Food and Drug Administration (FDA) announced on March 21. The action was based ...

This Practice Point commentary discusses a recent paper by Hoving et al., who compared the cost-effectiveness of continuous intrathecal baclofen infusion (CIBI) with that of 'standard care' in ...

Over 10 years, beginning during the original multicenter clinical trial, 140 people were referred for evaluation for potential screening trial, implantation, and management of ITB therapy. Of these, ...

Reports of pump failure, dosing errors, as well as other possible safety issues have prompted the Agency to issue the alert to make prescribers aware of the dangers associated with using medications ...

image: Transduced cells cluster around blood vessels in the rat brain after intrathecal AAV9 infusion. AAV9 in the cerebrospinal fluid is thought to enter the brain by flow along the Virchow Robin ...

Researchers have generated more preclinical evidence that intranasal delivery can get antibodies to the brain, presenting data that suggest the administration route can achieve concentrations close to ...

DEERFIELD, Ill., July 18, 2025--(BUSINESS WIRE)--TerSera Therapeutics LLC, a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management, announced today that its ...

Infusion pump maker Flowonix Medical has been working hard this past year to beef up development for its drug delivery device, raising new funds and partnering with biotech Cebebral Therapeutics to ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...